ANTIKOR BIOPHARMA LIMITED Financials
- Company number
- 04170519Copy
Copy - Industry
- Other research and experimental development on natural sciences and engineering (72.19 - SIC 2007)
- Registered office
- 80 Cheapside, London EC2V 6EE
- Incorporated
- 01/03/2001
Company snapshot
- Status
- Active
- Employees
- 0 (2025)
- Latest financial data
- 2025
- Accounts type
- Total Exemption Full
Financial highlights
Latest reported figures. Okredo holds filed data for 2021–2025.
Net Assets
4.36%vs 20242024: £8.81M
Total Assets
0.38%vs 20242024: £429.11K
Cash in Bank
423.56%vs 20242024: £20.80K
Total Liabilities
20.51%vs 20242024: £3.70M
Employees
0vs 20242024: 0
In 2025, ANTIKOR BIOPHARMA LIMITED reported net assets of £9.20M. The same filing shows total assets of £430.75K, cash in bank of £108.89K and total liabilities of £4.46M. Reported headcount was 0 in 2025. Total Liabilities rose from £3.70M in 2024 to £4.46M in 2025 (20.51%). Okredo holds filed figures for 2021–2025; the table below lists every reported indicator by year. See every reported indicator by year.
Financial performance
Pick a measure to see how it has moved across the reported years, with the year-on-year change beneath it.
Net Assets
4.36%from £8.81M in 2024Year-on-year change
Net Assets as filed for 2021–2025. Every figure in this chart is also in the financial history table.
3-year financial trend (2023–2025)
How the figures ANTIKOR BIOPHARMA LIMITED filed moved across the three reported years 2023, 2024 and 2025 — measured end to end rather than year on year.
Net Assets
+10.8%vs 2023+5.2% a year compound (CAGR)
Cash in Bank
-50.1%vs 2023-29.4% a year compound (CAGR)
Total Assets
+489%vs 2023+143% a year compound (CAGR)
Employees
-100%vs 2023-13Biggest increase
Total Assets+489%
£73.12K in 2023 to £430.75K in 2025
Biggest decrease
Employees-100%
13 in 2023 to 0 in 2025
ANTIKOR BIOPHARMA LIMITED's filings pull in both directions between 2023 and 2025. The steepest rise came in total assets, pointing to a broader asset base, set against a fall in employee numbers, pointing to a smaller workforce. See the full year-by-year figures.
Ratios from the filed figures
Calculated from ANTIKOR BIOPHARMA LIMITED's own reported amounts, each shown against the year it was derived from — nothing here is estimated or industry-averaged.
- Net assets to total assets
- 2,135.59%2025
- Liabilities to total assets
- 1,035.53%2025
- Cash to liabilities
- 2.44%2025
- Cash to total assets
- 25.28%2025
Reported net assets divided by reported total assets, for the latest year both were filed. Shows how much of the asset base is not financed by liabilities.
Total liabilities divided by reported total assets, for the latest year both were available. Shows how much of the asset base is funded by obligations.
Reported cash in bank divided by total liabilities for the same year. Shows what share of outstanding obligations the reported cash balance would cover.
Reported cash in bank divided by reported total assets, for the latest year both were filed.
Financial history
Every indicator Okredo tracks, year by year.
Reported financial indicators for ANTIKOR BIOPHARMA LIMITED by year. Amounts are as filed; a dash means the figure was not reported for that year.
| Indicator | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net Assets£ | 6.23M | 6.64M | 8.31M | 8.81M | 9.20M |
| Total Assets£ | 108.30K | 75.72K | 73.12K | 429.11K | 430.75K |
| Cash in Bank£ | 132.91K | 341.95K | 218.25K | 20.80K | 108.89K |
| Total Liabilities£ | – | – | – | 3.70M | 4.46M |
| Employees | 12 | 11 | 13 | 0 | 0 |
ANTIKOR BIOPHARMA LIMITED financials: frequently asked questions
Answered from this company's own filed figures.
Has ANTIKOR BIOPHARMA LIMITED filed financial statements?
Yes. Okredo holds filed figures for ANTIKOR BIOPHARMA LIMITED covering 2021–2025, across 5 reported indicators. The most recent reported year is 2025.
What net assets did ANTIKOR BIOPHARMA LIMITED report in 2025?
ANTIKOR BIOPHARMA LIMITED reported net assets of £9.20M for 2025. That compares with £8.81M in 2024, a change of 4.36%.
What total assets did ANTIKOR BIOPHARMA LIMITED report in 2025?
ANTIKOR BIOPHARMA LIMITED reported total assets of £430.75K for 2025. That compares with £429.11K in 2024, a change of 0.38%.
What cash in bank did ANTIKOR BIOPHARMA LIMITED report in 2025?
ANTIKOR BIOPHARMA LIMITED reported cash in bank of £108.89K for 2025. That compares with £20.80K in 2024, a change of 423.56%.
How many people does ANTIKOR BIOPHARMA LIMITED employ?
ANTIKOR BIOPHARMA LIMITED reported 0 employees in 2025, compared with 0 in 2024.
How have ANTIKOR BIOPHARMA LIMITED financials changed over the last 3 years?
Between 2023 and 2025, ANTIKOR BIOPHARMA LIMITED's net assets rose by 10.8%, cash in bank fell by 50.1%, total assets rose by 489% and employee numbers fell by 100%. Net assets compounded at 5.2% a year across the two years to 2025, from £8.31M to £9.20M. Reported headcount went from 13 in 2023 to 0 in 2025 (-13).
Which years of ANTIKOR BIOPHARMA LIMITED financial data are available?
Okredo holds reported figures for the years 2021, 2022, 2023, 2024, 2025. Where an indicator was not reported for a given year, the financial history table shows a dash rather than a value.